(Q36471916)

14 August 2017

1 reference

title

Development of cattle TB vaccines in the UK. (English)

1 reference

14 August 2017

Martin Vordermeier

1

1 reference

14 August 2017

R Glyn Hewinson

series ordinal

2

1 reference

14 August 2017

language of work or name

1 reference

8 May 2006

1 reference

Veterinary Immunology and Immunopathology

14 August 2017

published in

1 reference

14 August 2017

volume

112

1 reference

14 August 2017

issue

1-2

1 reference

14 August 2017

page(s)

38-48

1 reference

Genomic approach to identification of Mycobacterium bovis diagnostic antigens in cattle

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Comparative genomics of BCG vaccines by whole-genome DNA microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Vaccination of cattle against Mycobacterium bovis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Use of ESAT-6 in the interferon-gamma test for diagnosis of bovine tuberculosis following skin testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

A DNA vaccine encoding MPB83 from Mycobacterium bovis reduces M. bovis dissemination to the kidneys of mice and is expressed in primary cell cultures of the European badger (Meles meles)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Prime-boost strategies for malaria vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

The complete genome sequence of Mycobacterium bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Protective efficacy induced by Mycobacterium bovis bacille Calmette-Guèrin can be augmented in an antigen independent manner by use of non-coding plasmid DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

CpG oligodeoxynucleotides enhance host defense during murine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Use of CpG oligodeoxynucleotides as immune adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Developing an improved vaccine against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Progress in DNA-based heterologous prime-boost immunization strategies for malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Biological activity of immunostimulatory CpG DNA motifs in domestic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Prospects for a better vaccine against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Vaccination of animals against Mycobacterium bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Toward the development of diagnostic assays to discriminate between Mycobacterium bovis infection and bacille Calmette-Guérin vaccination in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

In vitro immunodiagnostic assays for bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Ten years of research progress and what's to come

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Effective, nonsensitizing vaccination with culture filtrate proteins against virulent Mycobacterium bovis infections in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETIMM.2006.03.010

1 reference

14 August 2017

1 reference